Actinogen Medical Limited Stock Net Income
| ATGGF Stock | USD 0.04 0.00 0.00% |
As of the 26th of January, Actinogen Medical shows the Standard Deviation of 7.39, mean deviation of 1.79, and Risk Adjusted Performance of 0.0991. Actinogen Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Actinogen Medical standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if Actinogen Medical is priced correctly, providing market reflects its regular price of 0.04 per share. As Actinogen Medical appears to be a penny stock we also recommend to validate its information ratio numbers.
Actinogen Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Actinogen Medical's valuation are provided below:Actinogen Medical Limited does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Actinogen |
Actinogen Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Actinogen Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Actinogen Medical.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Actinogen Medical on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Actinogen Medical Limited or generate 0.0% return on investment in Actinogen Medical over 90 days. Actinogen Medical is related to or competes with Telescope Innovations, Propanc Biopharma,, Cell Source, and Zenith Capital. Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic ... More
Actinogen Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Actinogen Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Actinogen Medical Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1125 | |||
| Maximum Drawdown | 60.0 |
Actinogen Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Actinogen Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Actinogen Medical's standard deviation. In reality, there are many statistical measures that can use Actinogen Medical historical prices to predict the future Actinogen Medical's volatility.| Risk Adjusted Performance | 0.0991 | |||
| Jensen Alpha | 0.7693 | |||
| Total Risk Alpha | 0.2096 | |||
| Treynor Ratio | 0.4736 |
Actinogen Medical January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0991 | |||
| Market Risk Adjusted Performance | 0.4836 | |||
| Mean Deviation | 1.79 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 7.39 | |||
| Variance | 54.55 | |||
| Information Ratio | 0.1125 | |||
| Jensen Alpha | 0.7693 | |||
| Total Risk Alpha | 0.2096 | |||
| Treynor Ratio | 0.4736 | |||
| Maximum Drawdown | 60.0 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Actinogen Medical Backtested Returns
Actinogen Medical appears to be out of control, given 3 months investment horizon. Actinogen Medical secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing Actinogen Medical's technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please makes use of Actinogen Medical's Standard Deviation of 7.39, risk adjusted performance of 0.0991, and Mean Deviation of 1.79 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Actinogen Medical holds a performance score of 9. The firm shows a Beta (market volatility) of 1.9, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Actinogen Medical will likely underperform. Please check Actinogen Medical's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Actinogen Medical's price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Actinogen Medical Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Actinogen Medical time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Actinogen Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Actinogen Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Actinogen Medical Limited reported net income of (9.5 Million). This is 102.78% lower than that of the Healthcare sector and 113.56% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.66% higher than that of the company.
Actinogen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Actinogen Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Actinogen Medical could also be used in its relative valuation, which is a method of valuing Actinogen Medical by comparing valuation metrics of similar companies.Actinogen Medical is currently under evaluation in net income category among its peers.
Actinogen Fundamentals
| Return On Equity | -0.48 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (2.61) % | |||
| Operating Margin | (2.62) % | |||
| Current Valuation | 125.91 M | |||
| Shares Outstanding | 1.81 B | |||
| Shares Owned By Insiders | 19.67 % | |||
| Shares Owned By Institutions | 14.99 % | |||
| Price To Book | 12.26 X | |||
| Price To Sales | 49.62 X | |||
| Revenue | 3.64 M | |||
| Gross Profit | 3.64 M | |||
| EBITDA | (9.08 M) | |||
| Net Income | (9.5 M) | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 10.98 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.52 M) | |||
| Earnings Per Share | (0) X | |||
| Beta | 2.01 | |||
| Market Capitalization | 116.56 M | |||
| Total Asset | 23.31 M | |||
| Net Asset | 23.31 M |
About Actinogen Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Actinogen Medical Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Actinogen Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Actinogen Medical Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Actinogen Pink Sheet
Actinogen Medical financial ratios help investors to determine whether Actinogen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Actinogen with respect to the benefits of owning Actinogen Medical security.